INS and metabolic syndrome: Dyslipidemia represents another factor underlying the strong association between CVD and MAFLD: impaired lipid metabolism is associated with upregulation of the transcription factor sterol regulatory element binding protein-1c (SREBP-1c), which is responsible, along with insulin, for the expression of genes involved in de novo lipogenesis, as well as for inhibition of FFA oxidation.